Significant expression patterns of Lewis x-related antigens as a prognostic predictor of low-stage renal cell carcinomas

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 593-599

  Kobayashi, Minoru ^a   Morita, Tatsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Prognosis; Renal cell carcinoma; Sialyl Lewis x

Indexed keywords

ALPHA INTERFERON; FLUOROPYRIMIDINE; INTERLEUKIN 2; SIALYL LEWIS X ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD15; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGOSACCHARIDES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950537103     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ficarra V, Guillè F, Schips L, de la Taille A, Prayer Galetti T, Tostain J, Cindolo L, Novara G, Zigeuner R, Bratti E, Li G, Altieri V, Abbou CC, Zanolla L, Artibani W and Patard JJ: Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 104: 2116-2123, 2005.
2. Minervini A, Di Cristofano C, Collecchi P, Salinitri G, Selli C, Bevilacqua G, Minervini R and Cavazzana A: Intracapsular clear cell renal carcinoma: ploidy status improves the prognostic value of the 2002 TNM classification. J Urol 174: 1203-1207; discussion 1207, 2005.
3. Magnani JL: The tumor markers, sialyl Le(a) and sialyl Le(x) bind ELAM-1. Glycobiology 1: 318-320, 1991.
4. Irimura T: Cancer metastasis determined by carbohydrate-mediated cell adhesion. Adv Exp Med Biol 353: 27-34, 1994.
5. Patel TP, Goelz SE, Lobb RR and Parekh RB: Isolation and characterization of natural protein-associated carbohydrate ligands for E-selectin. Biochemistry 13: 14815-14824, 1994.
6. Stone JP and Wagner DD: P-Selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92: 804-813, 1993.
7. Pottratz ST, Hall TD, Scribner WM, Jayaram HN and Natarajan V: P-selectin-mediated attachment of small cell lung carcinoma to endodielial cells. Am J Physiol 271: 918-923, 1996.
8. Mitsuoka C, Kawakami-Kimura N, Kasugai-Sawada M, Hiraiwa N, Toda K, Ishida H, Kiso M, Hasegawa A and Kannagi R: Sulfated sialyl Lewis X, the putative L-selectin ligand, detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies. Biochem Biophys Res Commun 230: 546-551, 1997.
9. Izawa M, Kumamoto K, Mitsuoka C, Kanamori C, Kanamori A, Ohmori K, Ishida H, Nakamura S, Kurata-Miura K, Sasaki K, Nishi T and Kannagi R: Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res 60: 1410-1416, 2000.
10. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637, 1993.
11. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75: 2051-2056, 1995.
12. x: a new prognostic parameter in metastatic prostate cancer. Cancer Res 55: 1817-1819, 1995.
13. Ogawa J, Inoue H and Koide S: Expression of α-1,3- fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56: 325-329, 1996.
14. x expression in advanced gastric carcinoma. Br J Cancer 83: 1681-1687, 2000.
15. x expression defines invasive and metastatic properties of bladder carcinoma. Cancer 94: 673-685, 2002.
16. Fukushi Y, Ohtani H and Orikasa S: Expression of lacto series type 2 antigens in human renal cell carcinoma and its clinical significance. J Natl Cancer Inst 81: 352-358, 1989.
17. Tozawa K, Okamoto T, Kawai N, Hashimoto Y, Hayashi Y and Kohri K: Positive correlation between sialyl Lewis X expression and pathologic findings in renal cell carcinoma. Kidney Int 67: 1391-1396, 2005.
18. Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E and Hakomori S: Characterization of sialosylated Lewis x as a new tumor-associated antigen. Cancer Res 11: 5279-5285, 1984.
19. Fukushi Y, Nudelman E, Levery SB, Higuchi T and Hakomori S: Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 259: 10511-10517, 1984.
20. Dohi T, Nemoto T, Ohta S, Shitara K, Hanai N, Nudelman E, Hakomori S and Oshima M: Different binding properties of three monoclonal antibodies to sialylLe(x)glycolipids in a gastric cancer cell line and normal stomach tissue. Anticancer Res 13: 1277-1282, 1993.
21. Uchimura K, Muramatsu H, Kadomatsu K, Fan QW, Kurosawa N, Mitsuoka C, Kannagi R, Habuchi O and Muramatsu T: Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J Biol Chem 273: 22577-22583, 1998.
22. Cheville JC, Blute ML, Zincke H, Lohse CM and Weaver AL: Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J Urol 166: 453-456, 2001.
23. Minervini A, Lilas L, Minervini R and Selli C: Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal ceU carcinoma. Long-term analysis in 213 patients. Cancer 94: 2590-2595, 2002.
24. Parker AS, Cheville JC, Blute ML, Igel T, Lohse CM and Cerhan JR: Padiologic T1 clear cell renal cell carcinoma: insulin-like growdi factor-I receptor expression and disease-specific survival. Cancer 100: 2577-2582, 2004.
25. Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC and Blute ML: Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with low-stage clear cell renal cell carcinoma. Urology 65: 1090-1095, 2005.
26. Di Cristofano C, Minervini A, Menicagli M, Salinitri G, Bertacca G, Pefanis G, Masieri L, Lessi F, Collecchi P, Minervini R, Carini M, Bevilacqua G and Cavazzana A: Nuclear expression of hypoxia-inducible factor-1 alpha in clear cell renal cell carcinoma is involved in tumor progression. Am J Surg Pathol 31: 1875-1881, 2007.
27. Petretti T, Kemmner W, Schulze B and Schlag P: Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46: 359-366, 2000.
28. Kumamoto K, Goto Y, Sekikawa K, Takenoshita S, Ishida N, Kawakita M and Kannagi R: Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants. Cancer Res 61: 4620-4627, 2001.
29. Kemmner W, Roefzaad C, Haensch W and Schlag PM: Glycosyltransferase expression in human colonic tissue examined by oUgonucleotide arrays. Biochim Biophys Acta 1621: 272-279, 2003.